Back to top
more

USANA Health Sciences (USNA)

(Real Time Quote from BATS)

$42.60 USD

42.60
69,524

-0.38 (-0.88%)

Updated Apr 30, 2024 09:45 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

USANA Health Sciences (USNA) Q1 Earnings Lag Estimates

USANA Health (USNA) delivered earnings and revenue surprises of -7.64% and 2.52%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Sanghamitra Saha headshot

Apply DuPont Strategy to Pick 5 Top-Ranked Healthy Stocks

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

Jazz's (JAZZ) Vyxeos Gets FDA Nod for Pediatric Leukemia

Jazz Pharmaceuticals (JAZZ) gets FDA approval for label expansion of its cancer drug, Vyxeos, in pediatric patients with newly-diagnosed therapy-related acute myeloid leukemia.

Zacks.com featured highlights include: Medifast, 1800 FLOWERS.COM, USANA Health Sciences, UFP Industries and AllianceBernstein

Zacks.com featured highlights include: Medifast, 1800 FLOWERS.COM, USANA Health Sciences, UFP Industries and AllianceBernstein

Sanghamitra Saha headshot

5 Best Stocks to Buy After Analyzing ROE the DuPont Way

Delving into the basic ROE, with the help of DuPont analysis, before shortlisting stocks could lead to even better returns.

USNA vs. ZTS: Which Stock Should Value Investors Buy Now?

USNA vs. ZTS: Which Stock Is the Better Value Option?

USANA Health (USNA) Soars to 52-Week High, Time to Cash Out?

USANA Health (USNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sanghamitra Saha headshot

Explore 5 Top-Ranked Stocks Using the DuPont Analysis

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

USNA or ZTS: Which Is the Better Value Stock Right Now?

USNA vs. ZTS: Which Stock Is the Better Value Option?

Esperion (ESPR) Q4 Earnings Miss, Coronavirus Woes Continue

Esperion Therapeutics (ESPR) reports dismal fourth-quarter results as it misses estimates for earnings and sales. Sales were hurt due to COVID-19.

Jazz Pharma (JAZZ) Q4 Earnings Miss, 2021 Sales View Dull

Jazz Pharmaceuticals (JAZZ) reports mixed fourth-quarter 2020 results as earnings miss estimates while sales beat the same. Shares down.

Kinjel Shah headshot

5 Low Price-to-Book Stocks for Value Investors

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

Zacks Industry Outlook Highlights: Radius Health, USANA Health Sciences, Organogenesis Holdings, Turning Point Therapeutics and Oncternal Therapeutics

Zacks Industry Outlook Highlights: Radius Health, USANA Health Sciences, Organogenesis Holdings, Turning Point Therapeutics and Oncternal Therapeutics

Moving Average Crossover Alert: USANA Health Sciences (USNA)

USANA Health Sciences (USNA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Kinjel Shah headshot

5 Small Drug Stocks to Buy Amid Lingering COVID-Led Uncertainty

Some residual impact of the coronavirus pandemic is expected on the Medical-Drugs industry in 2021. However, with demand trends expected to improve, USNA, RDUS, ONCT, ORGO and TPTX may prove to be good additions to one's portfolio.

USNA vs. CTLT: Which Stock Is the Better Value Option?

USNA vs. CTLT: Which Stock Is the Better Value Option?

USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates

USANA Health (USNA) delivered earnings and revenue surprises of 34.53% and 8.31%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Pick USANA Health (USNA) Stock Now?

Is USANA Health Sciences (USNA) a great pick from the value investor's perspective right now? Read on to know more.

Jazz Pharma (JAZZ) Beats on Q3 Earnings, Ups Sales Guidance

Jazz Pharmaceuticals (JAZZ) reports better-than-expected third-quarter 2020 earnings and revenues and ups its sales guidance for 2020.

Is USANA Health Sciences (USNA) Stock Outpacing Its Medical Peers This Year?

Is (USNA) Outperforming Other Medical Stocks This Year?

USANA Health Sciences (USNA) Q3 Earnings and Revenues Top Estimates

USANA Health (USNA) delivered earnings and revenue surprises of 11.63% and 5.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sanghamitra Saha headshot

5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off

Why you should depend on the DuPont technique to pick solid profit-generating stocks.